Estrogen Receptor α Gene Variation Is Associated With Risk of Myocardial Infarction in More Than Seven Thousand Men From Five Cohorts

Authors:
  • JCJackie A. Cooper
    Jackie A. Cooper
  • PKPaul J. Kotwinski
    Paul J. Kotwinski
  • GMGeorge J. Miller
    George J. Miller
  • SHSteve E. Humphries
    Steve E. Humphries
  • KAKristin G. Ardlie
    Kristin G. Ardlie
  • BJBarbara Jordan
    Barbara Jordan
  • KIKathryn Irenze
    Kathryn Irenze
  • SSStephanie C. E. Schuit
    Stephanie C. E. Schuit
  • AUAndré G. Uitterlinden
    André G. Uitterlinden
  • HPHuibert A. P. Pols
    Huibert A. P. Pols

Abstract
Understanding the mechanisms by which estrogens affect cardiovascular disease risk, including the role of variation in the gene for estrogen receptor α ( ESR1 ), may be key to new treatment strategies. We investigated whether the CC genotype at ESR1 c.454-397T > C is associated with increased risk among men. Study of more than 7000 whites in 5 cohorts from 4 countries provided evidence that genotype CC , present in roughly 20% of individuals, is a risk factor for nonfatal acute myocardial infarction (odds ratio=1.44; P <0.0001), after adjustment for established cardiovascular risk factors. After exclusion of younger subjects from 2 cohorts, because of age interaction, the odds ratio increased (to 1.63).

This publication has 15 references indexed in Scilit: